Latest news with #Instem
Business Wire
18 hours ago
- Business
- Business Wire
Instem Announces Acquisition of RockStep Solutions, Inc.
BOSTON & STAFFORDSHIRE, England--(BUSINESS WIRE)--Instem is excited to announce that as of today it has closed on an acquisition of RockStep Solutions. RockStep is the provider of Climb™, a cloud-based software solution for non-GLP preclinical study management. The acquisition of RockStep enables Instem to now provide an integrated solution of both Provantis ®, Instem's market-leading solution for GLP preclinical study management, and Climb. The combined solution will offer best-in-class GLP study management design with the flexibility to support non-GLP studies and will be the most comprehensive and advanced software for any type of facility engaged in preclinical research. This fusion of products and technologies expands the Instem solution suite to manage breeding, handling, moving, or genotyping animals, subject census management, study design, PK/PD analysis, pathology management, necropsy, study data visualization features, and more. 'At Instem, our mission is to help our customers make discoveries, and to accelerate and advance their research programs. The acquisition of RockStep and integration of Climb into our Provantis platform strengthens this commitment, enabling a fully connected, end-to-end environment that spans from early discovery through non-GLP and GLP study management to regulatory submission. By unifying these workflows under one provider, we help reduce risk, eliminate inefficiencies, and drive greater scientific and operational impact across the preclinical R&D lifecycle.' Vik Krishnan, CEO, Instem. The acquisition of RockStep adds many new large and industry-leading customers in the pharmaceutical and CRO spaces. Instem and RockStep together form the most experienced and talented team dedicated to the management and analysis of preclinical research data. The solution suite is significantly expanded to assemble a complete enterprise system for preclinical study management, tracking all aspects of breeding, census, veterinary procedures, study design and execution, including PK/PD analysis, along with data visualization and analytics. Climb offers a technologically advanced, flexible platform for non-GLP study designs and facilitates vivarium management, including animal health tracking and real-time alerts. This combined solution suite unifies teams and acts as a data hub, allowing scientists and lab staff to collaborate and communicate from anywhere. Large Pharma, Biotech, and CROs need flexibility and the ability to operate across different workstreams, studies, research types, and disease areas, which Instem is now able to offer through the combination of Provantis and Climb. About Instem Instem is a leading supplier of SaaS platforms across Discovery, Study Management, Regulatory Submission and Clinical Trial Analytics. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products. Founded in the United Kingdom in 1969, Instem has deep roots internationally across North America, EMEA and APAC. Instem maintains a commercial and technical presence throughout these regions, and we pride ourselves on localized support for our diverse client base. Learn more about Instem here: About RockStep Solutions, Inc. RockStep Solutions was founded in 2013 by Chuck Donnelly, a software engineer with experience working for life sciences companies, and Julie Morrison, a microbiology scientist. Since these early beginnings, RockStep has maintained a strong commitment to innovation, today partnering with Microsoft to integrate advanced technologies in the Azure cloud into our industry-leading Climb™ software. Launched in 2017, Climb has been adopted by a wide range of life sciences innovators – from global pharmaceutical companies and CROs to biotech organizations, government labs, a Nobel Laureate's lab at UCSF, and research labs at The Jackson Laboratory.
Business Wire
23-06-2025
- Business
- Business Wire
Driving Pathology Forward: Instem Strengthens Provantis ® with Continued Investment and Innovation
BOSTON--(BUSINESS WIRE)--Instem, a global leader in life sciences software solutions, today announced significant enhancements to its Provantis Pathology module, a cornerstone of the company's industry-leading platform for preclinical study management. These latest innovations reflect Instem's ongoing commitment to modernizing pathology workflows through advanced digitization and seamless integration. Deep Digital Integration Provantis Pathology now offers enhanced support for digital pathology, allowing users to move effortlessly between Provantis data entry and external applications or data sources. A key highlight is the new, seamless integration with PathcoreFlow™, the powerful digital slide management system from Instem's strategic partner, Pathcore ®. This integration bridges study management and high-resolution digital slide review, resulting in a more connected, consistent, and efficient pathology workflow. The connection - and its time-saving benefits - is now available for pathologists to implement in their research. 'Digital pathology is no longer a niche - it's a vital foundation for faster, more reliable preclinical insights,' said Charuta Bapat, Director of Product - Study Management at Instem. 'With the latest updates to our Provantis Pathology module and the upcoming release of Provantis 12, we're delivering the most advanced tools designed to help pathologists work more efficiently and with greater confidence.' 'We're incredibly proud of what this integration represents - a fully connected, digitally forward workflow for today's pathology professionals,' said Carlos Frade, Senior Director of Product Knowledge and Business Development at Instem. 'This is a huge step forward for our study management solutions, and we're excited to meet with Pathologists at STP to showcase everything Provantis can do.' Instem's commitment to a more flexible, future-ready environment is further reinforced by Provantis' growing suite of APIs connecting to 19 different data domains. This includes enhanced Pathology APIs for smoother integration with digital platforms, along with Preclinical Libraries and Studies APIs to extend data interoperability. Looking ahead in 2025, the upcoming Provantis 12 release will lay the groundwork for a new, non-GLP pathology solution. This module will enable more pathologists to integrate with the Provantis ecosystem - supporting protocol definition, necropsy, and reporting - and empowering pathology teams to work smarter and faster with minimal disruption. Live Demonstrations at STP 2025 Instem's pathology team will be demonstrating these new features live at the STP Annual Symposium in Chicago, exploring: New editing capabilities in the histopathology matrix, as part of the upcoming non-GLP pathology module. A new integration in this module with smart glossaries for simplified terminology management. How to get started with the Provantis and PathcoreFlow™ integration These advancements are part of Instem's broader roadmap focused on efficiency, scalability, and comprehensive study support for your lab team. For details on how Provantis is transforming digital pathology visit To schedule a live demo during or after the STP conference in Chicago, contact info@ About Instem Instem is a leading supplier of SaaS platforms across Discovery, Study Management, Regulatory Submission and Clinical Trial Analytics. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products. Founded in the United Kingdom in 1969, Instem has deep roots internationally across North America, EMEA, and APAC. Instem maintains a commercial and technical presence throughout these regions and prides itself on localized support for its diverse client base. LinkedIn About Pathcore Pathcore ® is dedicated to advancing digital pathology through innovative software solutions that empower organizations with the tools they need to implement digital transformations. For over two decades, our co-founders have led and developed widely used platforms including PathcoreFlow™, the Sedeen Viewer™, and PathcoreScholar™. Our applications support a wide range of clients in more than 68 countries and 2000 organizations, making data easily accessible and driving the adoption of digital pathology.
Business Wire
20-05-2025
- Business
- Business Wire
Instem Announces Acquisition of Strong Tower Solutions, Strengthening its Clinical SCE Solutions
BOSTON & DOWNINGTOWN, Pa. & STAFFORDSHIRE, England--(BUSINESS WIRE)--Instem is excited to announce that it has closed on an acquisition of Strong Tower Solutions, a technology-enabled service provider with nearly 20 years of configuring and installing qualified, validated, and compliant statistical computing environment (SCE) systems. Strong Tower Solutions is a Pennsylvania-based company that provides technology solutions and services to life sciences customers proceeding through clinical trials. 'Our mission is to help our customers make discoveries, and to accelerate and advance their research programs. By joining forces with Strong Tower Solutions, we're enabling faster, more effective decision-making with reduced risk in clinical development. As the regulatory landscape evolves, Instem's end-to-end platform, and our growing leadership in SCE, becomes even more critical to our customers' success.' Vik Krishnan, CEO, Instem Bringing Instem and Strong Tower Solutions together allows Instem to better serve the clinical market and expands product offerings to small and large life sciences customers. Clients choose Instem and STS because they stay current on best practices and thought leadership in SCE, deploying environments according to their specific needs. These SCE solutions provide customers with the ability to focus on bringing drugs to market while remaining compliant with regulators. 'Instem is at the forefront of SCE modernization. This acquisition of Strong Tower Solutions is a testament to our unwavering commitment to innovation in clinical computing. By integrating STS's expertise with our own, we are accelerating the transformation towards open systems that enhance cloud-based analysis and reporting. This strategic move not only complements our previous acquisition of d-wise but also solidifies Instem's position as a leader in the field. Instem's thought leadership and SCE are increasingly synonymous. Together, we are empowering our clients to simplify and modernize their Statistical Computing Environments, driving faster, compliant drug development.' Stephen Baker, General Manager of Instem's Clinical division. 'Our team at Strong Tower Solutions has always been dedicated to delivering precisely configured, fully compliant computing environments. By joining Instem, customers will benefit from access to additional resources, cloud native technologies, and cross disciplinary expertise. We look forward to combining our deep domain knowledge and services with Instem's offerings to drive more value for customers and be ahead of industry shifts.' John Norton. Director of Customer Success, Strong Tower Solutions. The Instem clinical segment focuses on being the pre-eminent thought leader in SCE innovation with software, services, and advice for life sciences customers. It offers flexibility and supports the evolution of the market towards next-gen SCE. Strong Tower Solutions complements Instem as another trusted advisor to clients undergoing clinical trials. About Instem Instem is a leading supplier of SaaS platforms across Discovery, Study Management, Regulatory Submission and Clinical Trial Analytics. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products. Founded in the United Kingdom in 1969, Instem has deep roots internationally across North America, EMEA and APAC. Instem maintain a commercial and technical presence throughout these regions and pride ourselves on localized support for our diverse client base. About Strong Tower Solutions Strong Tower Solutions brings decades of unwavering dedication to navigating the complexities of data management and business analytics. We stand as a beacon of reliability and innovation in the realm of statistical computing and data management, empowering organizations to unlock new opportunities and redefine their potential for success. We help life sciences companies in all stages of the clinical lifecycle navigate their data and statistical computing demands in a way that is scalable, validated, and compliant. Learn more about Strong Tower Solutions here:
